The global stent market is projected to reach $19.8 billion by 2028, at a CAGR of 8.9% during 2023-2028. The growth of stent market is driven by increasing interventional cardiology and peripheral vascular procedures and rising adoption of technological advancements in an effort to reduce treatment duration for high risk conventional surgical patients.
Some of the Key Questions answered in this exclusive report are:
Q.1 What are some of the most promising, high-growth opportunities for the stent market by product type (coronary stent and peripheral vascular stent), material (metal and polymer), technology (bare metal stent, drug eluting stent, and bioreabsorbable stent), end use (hospital and ambulatory surgical center), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 What are the business risks and threats to the stent market?
Q.4 What are some changing demands of customers in the stent market?
Q.5 What are the new developments in the stent market? Which companies are leading these developments?
Q.6 What strategic initiatives are being implemented by key players for business growth?
Q.7 What are some of the competitive products and processes in this stent area and how big of a threat do they pose for loss of market share via product substitution?
Q.8 What M&A activity has occurred in the last 5 years in this stent market?
Emerging trends, which have a direct impact on the dynamics of the industry, include increasing use of bioreabsorbable stent, increasing adoption of co-polymers as raw materials, and increasing adoption of bifurcated stents.
Market Segmentation:
Based on product type, the stent market is segmented into coronary stent and peripheral vascular stent. The coronary stent segment accounted for the largest share of the market in 2023 and is expected to register the highest CAGR during the forecast period, due to increasing cases of cardiovascular disorders.
North America is expected to remain the largest market during the forecast period mainly due to its well-developed healthcare infrastructure and continued technological advancements across the healthcare industry.
Key Players in the stent market are Abbott Laboratory, Boston Scientific, Medtronic public limited company, C R Bard, Cook Medical Inc., Terumo Corporation, and Cardinal Health.
Request Sample Pages by clicking on https://www.lucintel.com/stents-market.aspx
The report helps stakeholders understand the pulse of the market and provides them with information on key drivers, restraints, challenges, and opportunities for market growth. It would also help to understand the competitors better and gain more insights to improve their position in the business.
To read more about this market please click on https://www.lucintel.com/stents-market.aspx
About Lucintel
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.
Roy AlmaguerLucintel Dallas, Texas, USA Email: roy.almaguer@lucintel.com Tel. 972.636.5056
Media Contact
Company Name: Lucintel
Contact Person: Roy Almaguer
Email: Send Email
Phone: 972.636.5056
Address:8951 Cypress Waters Blvd., Suite 160
City: Dallas
State: TEXAS
Country: United States
Website: https://www.lucintel.com/